BioCentury Article: ASF And FAST To Collaborate With Ovid Therapeutics

BioCentury Article: ASF And FAST To Collaborate With Ovid Therapeutics.

Ovid is working with patients and families to develop failed drugs for rare and Orphan brain diseases, starting with Angelman syndrome . . .